Daniel Karmelic Visinteiner, PhD
Associate Specialist
Biochemistry and Biophysics
School of Medicine
daniel.karmelic@ucsf.edu 415-476-2699
Publications (3)
Top publication keywords:
Brain ChemistryReceptors, N-Methyl-D-AspartateAlzheimer DiseaseHippocampusPeroxisome ProliferatorsSynapsesLong-Term PotentiationNeuronal PlasticityNerve DegenerationUp-RegulationCalcium-Binding ProteinsMammalsMemory DisordersNeurotransmitter AgentsHomeostasis
-
NMDAR-dependent presynaptic homeostasis in adult hippocampus: Synapse growth and cross-modal inhibitory plasticity.
Neuron 2022 Chipman PH, Fetter RD, Panzera LC, Bergerson SJ, Karmelic D, Yokoyama S, Hoppa MB, Davis GW -
CaMKII inhibitor 1 (CaMK2N1) mRNA is upregulated following LTP induction in hippocampal slices.
Synapse (New York, N.Y.) 2020 Astudillo D, Karmelic D, Casas BS, Otmakhov N, Palma V, Sanhueza M -
Peroxisome proliferators reduce spatial memory impairment, synaptic failure, and neurodegeneration in brains of a double transgenic mice model of Alzheimer's disease.
Journal of Alzheimer's disease : JAD 2013 Inestrosa NC, Carvajal FJ, Zolezzi JM, Tapia-Rojas C, Serrano F, Karmelic D, Toledo EM, Toro A, Toro J, Santos MJ